Medicine for external application for treating pyogenic type contaminated wounds

Abstract

The invention discloses a medicine for external application for treating pyogenic type contaminated wounds, which is characterized by comprising the following raw materials in the proportion by weight: 20-60 of catechu, 15-45 of dragon blood, 25-60 of prepared frankincense, 25-60 of prepared myrrh, 50-150 of calcined dragon bone, 60-200 of calcined gypsum, 20-60 of red halloysite, 40-80 of pearl, 0.5-1.0 of musk, 2-5 of borneol and 2-5 of calomel. The medicine for external application has the efficacies of diminishing inflammation and relieving pain, removing necrosis and promoting granulation, promoting discharge of venom, increasing the amount of blood supply, activating cell growth, accelerating growth of granulation tissue and promoting wounds to heal quickly. The medicine for external application is used for treating various pyogenic type contaminated wounds of dermis, fat, muscle, aponeurosis and periosteum. After clinical application for many years, the medicine for external application has good treating effect, and the healing rate reaches 90 percent. The course of treatment is generally ten days to two months, the healed wounds have unobvious scars, and patients have slight or no functional disorder.

Description

technical field [0001] The invention belongs to traditional Chinese medicines, and in particular relates to an external medicine for treating suppurative infection wounds. Background technique [0002] Generally superficial infection wounds, there are many external medicines for its treatment on the market, especially some Chinese herbal medicines have better curative effect. However, for severe suppurative infection wounds, up to now, there is not any topical medicine that can cure it on the market, and it is usually treated by surgical operations. Because infected wounds are healed by second intention, especially for severe suppurative infected wounds, surgical treatment takes a long time, costs high, and the scars after healing are large, and even local dysfunction exists. Contents of the invention [0003] The object of the present invention is to provide an external medicine capable of treating severe suppurative infection wounds with good therapeutic effect. [000...

AI Technical Summary

Problems solved by technology

However, for severe suppurative infection wounds, up to now, there is no external drug that can cure it on the market, and it is usually treated by surgery.

Since infected wounds are healed by second intention, especially for severe purulent infected wounds, surgical treatment takes a long time, costs high, and the scars after healing are large, and even local dysfunction exists.